2020
DOI: 10.1016/j.tiv.2019.104681
|View full text |Cite
|
Sign up to set email alerts
|

Human CYP1A1 inhibition by flavonoids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 43 publications
3
17
0
Order By: Relevance
“…Other naturally occurring polyphenolic compounds, such as galangin (3,5,7-trihydroxyflavone) and apigenin (5,7,4-trihydroxyflavone) also inhibit CYP1A1 and CYP1A2 activities [ 49 ]. Reported values of apparent Ki for the inhibition of CYP1A1by galangin is 0.015 µM [ 50 ] and 0.32 µM apigenin [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Other naturally occurring polyphenolic compounds, such as galangin (3,5,7-trihydroxyflavone) and apigenin (5,7,4-trihydroxyflavone) also inhibit CYP1A1 and CYP1A2 activities [ 49 ]. Reported values of apparent Ki for the inhibition of CYP1A1by galangin is 0.015 µM [ 50 ] and 0.32 µM apigenin [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Dietary factors such as phytochemicals affect CYP expression and activity which may be of importance in diet-drug interactions. Several studies evidenced the inhibitory properties of flavonoids by structural interference with CYP proteins [ 167 ]. Additionally, soy components seem to promiscuously modulate several nuclear receptors including AhR, PXR, PPAR and liver X receptor (LXR), altering drug pharmacokinetics and therapeutic efficacy [ 168 ] ( Figure 5 ).…”
Section: Nongenetic Factors Influencing Cytochrome P450s Expression and Activitymentioning
confidence: 99%
“…Activated K-RAS also inhibits the degradation of ZNF304 transcription factor which is a transcriptional regulator of tumorsuppressor β1 integrin [34]. However, resveratrol [35], EGCG [36] and myricetin [37] can ameliorate these harmful effects by inhibiting the enzyme CYP1A1, which activates the procarcinogenic form of DMBA to an active carcinogen (while DMBA induce CYP1A1) [38]. This was confirmed by our results, where all tested substances significantly inhibited hypomethylation; moreover, hypermethylation was observed in the flavonoid consuming group compared to the untreated controls compared with other chemopreventive substances (Figs 1-3).…”
Section: Discussionmentioning
confidence: 99%